Search

Abstract “Tissue engineering,” is a concept that involves the use of scaffolds, cells, and growth factors/signaling molecules in the field of regenerative medicine. The present study was carried out to evaluate the attachment and depth of penetration of the Gingival Mesenchymal Stem Cells (GMSCs) onto the collagen scaffold preconditioned with Fetal Bovine Serum (FBS), Injectable Platelet Rich Fibrin (i-PRF) and a combination of FBS with i-PRF using histological analysis and environmental scanning electron microscopy (ESEM) respectively. In the present study, commercially available collagen membranes were used as scaffolds and divided into 3 groups where Group I was preconditioned with FBS, Group II was preconditioned with i-PRF, and Group III with a combination of FBS and i-PRF. Scaffolds were then seeded with GMSCs and incubated in a CO2 incubator at 37 0C for 7 days. Both histological and ESEM analysis showed proliferation, attachment, and depth of penetration along with the combination of cell morphological changes in all the three groups. In group I cells showed mild depth of penetration along with a round morphological appearance. In group II the cells showed moderate depth of penetration and rounded morphology. In group III maximum depth of penetration was seen along with the round and spheroidal morphology of cells. The combination of the growth media showed the best effect on cell attachment, depth of penetration, and cell morphology. This is the first report demonstrating the effect of the combination of collagen and i-PRF supports the proliferation of GMSCs. Since FBS alone and i-PRF alone exhibited similar cell proliferation it is recommended that i-PRF could be used in clinical scenarios making it xenofree.

Investments in Industry 4.0 are making a significant impact on various sectors by integrating advanced digital technologies. The chances of financial losses for organisations' investments due to new technologies are high, and there is a low possibility of recovering the investments. Reduced spending on long-term costs by organisations due to low investments and consumer demand for durable goods has resulted in sluggish global trade in advanced and emerging markets. Challenges have arisen for companies in securing loans for investments due to past economic slowdowns, resulting in increased corporate borrowing expenses. The literature acknowledges Supply Chain Finance (SCF) as a vital approach to optimising efficiency. Industry leaders are turning to SCF as high costs persist during the transformation process for manufacturers. SCF can unlock substantial working capital by improving cash flow, which can be used to back essential business initiatives. This evolving environment presents opportunities and requires a deeper investigation of possibilities and challenges in advancing SCF to support Industry 4.0 efforts. Given this, the Special Issue released in the International Journal of Production Research pushes forward this crucial research focus. Nine articles accepted in this Special Issue used different methodologies, theories, and contexts to address research needs and offer valuable insights on supply chain finance and industry 4.0 investment challenges. This Editorial summarises these studies, emphasising possibilities for future research pathways. [ABSTRACT FROM AUTHOR]

Background With the increase in popularity of cannabis and its use and the lack of large‐scale data on cannabis use and venous thromboembolism and pulmonary embolism (PE), we used a nationally representative cohort of young adults (aged 18–44 years) to compare the odds of admissions and in‐hospital mortality of PE with and without cannabis use disorder (CUD). Methods and Results Identified patients with PE using the National Inpatient Sample (2018) were compared for baseline, comorbidities, and outcomes. Multivariable regression analysis, adjusted for covariates, was used to compare the odds of PE in young patients with CUD (CUD+) versus those without (CUD−) and those with prior venous thromboembolism. Propensity score–matched analysis (1:6) was also performed to assess in‐hospital outcomes. A total of 61 965 (0.7%) of 8 438 858 young adult admissions in 2018 were PE related, of which 1705 (0.6%) had CUD+. On both unadjusted (odds ratio, 0.80 [95% CI, 0.71–0.90]; P

Digital Twins (DTs) hold significant promise in addressing the challenges faced by food supply chains (FSCs). This paper aims to provide critical insights into the potential for Digital Twins to meet the key challenges of the FSC and establish a comprehensive conceptual framework for their implementation. Following a systematic literature review (SLR), the study identified 81 peer-reviewed, high-quality papers published over the last decade (2012–2023). The typology-driven thematic analysis emphasises the emergent nature of DTs within FSCs, highlighting their key characteristics including monitoring, real-time simulation, and scenario analysis. The identified characteristics, applications, implementation drivers and barriers of Digital Twin form the basis for a novel conceptual framework for implementing DTs in FSCs. Leveraging insights from Innovation Adoption Theory and the Technology-Organization-Environment (TOE) framework, the study outlines a structured five step implementation process divided into three stages. Notably, technology assessment and performance evaluation emerge as two innovative steps necessary for the successful implementation of DTs specifically, not previously considered by the theory. The study identifies promising avenues for future research. These findings provide invaluable guidance to researchers and practitioners seeking to embrace the potential of Digital Twin within the food industry. [ABSTRACT FROM AUTHOR]

Background: Traditionally, mechanical thrombectomy performed for pulmonary embolism (PE) necessitates the utilization of iodinated contrast. Intravascular ultrasound (IVUS) has been used as a diagnostic and therapeutic modality in the management of acute high and intermediate-risk PE. Recently, with the shortage of contrast supplies and the considerable incidence of contrast-induced acute kidney injury (CI-AKI), other safer and more feasible IVUS methods have become desirable. The purpose of this systematic review was to evaluate the importance of IVUS in patients with PE undergoing thrombectomy. Methods: Medline/PubMed, Embase, Scopus, and Google Scholar were searched for review studies, case reports, and case series. Clinical characteristics, outcomes and the usage of IVUS-guided mechanical thrombectomy during the treatment of acute high and intermediate-risk PE were examined in a descriptive analysis. Results: In this systematic review, we included one prospective study, two case series, and two case reports from July 2019 to May 2023. A total of 39 patients were evaluated; most were female (53.8%). The main presenting symptoms were dyspnea and chest pain (79.5%); three patients (7.9%) presented with syncope, one with shock and one with cardiac arrest. Biomarkers (troponin and BNP) were elevated in 94.6% of patients. Most patients (87.2%) had intermediate-risk PE, and 12.8% had high-risk PE. All patients presented with right-heart strain (RV/LV ratio ≥ 0.9, n = 39). Most patients (56.4%) had bilateral PE. Mechanical thrombectomy was performed using IVUS without contrast utilization in 39.4% of the patients. After the initial learning curve, contrast usage decreased gradually over time. There was a significant decrease in the composite mean arterial pressure immediately following IVUS-guided thrombectomy from 35.1 ± 7.2 to 25.2 ± 8.3 mmHg (p < 0.001). Post-procedure, there was no reported (0%) CI-AKI, no all-cause mortality, no major bleeding, or other adverse events. There was a significant improvement in symptoms and RV function at the mean follow-up. Conclusions: New evidence suggests that IVUS-guided mechanical thrombectomy is safe, with visualization of the thrombus for optimal intervention, and reduces contrast exposure.

Activation of the CXCL12/CXCR4/ACKR3 axis is known to aid myocardial repair through ischemia-triggered hypoxia-inducible factor-1α (HIF-1α). To enhance the upregulation of HIF-1α, we administered roxadustat, a novel prolyl hydroxylase inhibitor (PHI) clinically approved by the European Medicines Agency 2021 for the treatment of renal anemia, with the purpose of improving LV function and attenuating ischemic cardiomyopathy. Methods: We evaluated roxadustat’s impact on HIF-1 stimulation, cardiac remodeling, and function after MI. Therefore, we analyzed nuclear HIF-1 expression, the mRNA and protein expression of key HIF-1 target genes (RT-PCR, Western blot), inflammatory cell infiltration (immunohistochemistry), and apoptosis (TUNEL staining) 7 days after MI. Additionally, we performed echocardiography in male and female C57BL/6 mice 28 days post-MI. Results: We found a substantial increase in nuclear HIF-1, associated with an upregulation of HIF-1α target genes like CXCL12/CXCR4/ACKR3 at the mRNA and protein levels. Roxadustat increased the proportion of myocardial reparative M2 CD206+ cells, suggesting beneficial alterations in immune cell migration and a trend towards reduced apoptosis. Echocardiography showed that roxadustat treatment significantly preserved ejection fraction and attenuated subsequent ventricular dilatation, thereby reducing adverse remodeling. Conclusions: Our findings suggest that roxadustat is a promising clinically approved treatment option to preserve myocardial function by attenuating adverse remodeling.

Technology has revolutionized many walks of life from business to governance, learning to workplaces. This research aimed to examine students' perceptions towards the digital library services at Visvesvaraya National Institute of Technology. A survey of 176 engineering post-grads was used to accomplish this. Random sampling technique was used. Primary data collected through structured questionnaires. The research showed that respondents are aware of and use digital collections. The report examined students' views on internet libraries and digital collections. The survey also examined students' perceptions of digital library pros and cons. The digital library system's applicability was also examined, with a focus on the prototype model's course material presentation. The study showed that digital libraries can improve student learning. Studying student perspectives helps determine the efficacy and relevance of digital library services in academic settings. This research clarifies the existing state of digital library usage and lays the groundwork for improving digital library infrastructure and services to meet the changing needs of college students. [ABSTRACT FROM AUTHOR]

Research on Blockchain implementation in the Pharmaceutical Supply Chains (PSC) is lacking despite its strong potential to overcome conventional supply chain challenges. Thus, this study aims to provide critical insight into the nexus between Blockchain and PSC and further build a conceptual framework for implementation within the pharmaceutical industry. Following a systematic literature review and text mining approach, 65 interdisciplinary articles published between 2010 and 2021 were studied to capture the decade long developments. Descriptive and thematic analysis showcases nascent developments of Blockchain in PSC. The drivers and barriers to adoption, implementation stages, and applications identified through the thematic analysis guide in setting the agenda for future research, primarily focussing on the use of Blockchain for drug counterfeiting, recall issues, along with other sector-specific challenges such as patient privacy, regulations and clinical trials. Research on Blockchain for PSC has been slow compared to other sectors, but has accelerated since the Covid-19 pandemic. Identified influential factors, implementation process and apparent applications are expected to influence researchers and practitioners in developing a roadmap for adopting Blockchain in the pharmaceutical industry. The proposed conceptual framework is novel and provides valuable directions to producers, regulators and governments to implement Blockchain in the pharmaceutical industry. [ABSTRACT FROM AUTHOR]